Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS) - Kakkar, AK; Levine, MN; Kadziola, Z (J Clin Oncol, 2004)
et al.